Canadian biotechnology firm Kane Biotech Inc. is conducting a veterinary clinical trial for a water additive formulated to remove plaque from companion animals’ teeth, the Winnipeg, Manitoba-based company announced today.
The product, called StrixNB, uses food additives to inhibit biofilm formation and also kills bacteria embedded in preformed dental plaque, the company reported. It is intended to be added to a pet’s water on a daily basis, and could supplement or replace existing oral care treatments, said Gord Froehlich, CEO of Kane.
Froehlich would not disclose the specific ingredients used in StrixNB, since the product has a global patent pending.
The clinical trials are taking place exclusively in Canada, but if the product displays efficacy during the trials, the company will conduct a soft launch in both Canada and the United States later this year or early next year. StrixNB will be distributed exclusively through veterinary channels, Froehlich said.
“There are a lot of oral care products for pets that don’t really show a scientific advantage,” Froehlich said. “We believe ours does, so our plan is to market through veterinarians.”
The clinical trials will likely last until mid-December, depending on the number of pets enrolled.
Veterinary clinics in the United States and Canada interested in selling the product during the soft launch can contact Kane Biotech Inc. at firstname.lastname@example.org.